Compare ALEMBIC PHARMA with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA IPCA LABS ALEMBIC PHARMA/
IPCA LABS
 
P/E (TTM) x 28.9 25.9 111.5% View Chart
P/BV x 2.9 5.1 56.4% View Chart
Dividend Yield % 1.8 0.4 440.6%  

Financials

 ALEMBIC PHARMA   IPCA LABS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-21
IPCA LABS
Mar-21
ALEMBIC PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,1502,456 46.8%   
Low Rs5271,371 38.4%   
Sales per share (Unadj.) Rs274.4423.3 64.8%  
Earnings per share (Unadj.) Rs56.790.6 62.6%  
Cash flow per share (Unadj.) Rs66.0107.1 61.7%  
Dividends per share (Unadj.) Rs14.004.00 350.0%  
Avg Dividend yield %1.70.2 798.7%  
Book value per share (Unadj.) Rs260.9370.6 70.4%  
Shares outstanding (eoy) m196.56126.85 155.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.14.5 67.6%   
Avg P/E ratio x14.821.1 70.0%  
P/CF ratio (eoy) x12.717.9 71.0%  
Price / Book Value ratio x3.25.2 62.3%  
Dividend payout %24.74.4 558.9%   
Avg Mkt Cap Rs m164,818242,728 67.9%   
No. of employees `000NANA-   
Total wages/salary Rs m10,51210,136 103.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,93153,699 100.4%  
Other income Rs m8751,292 67.7%   
Total revenues Rs m54,80654,991 99.7%   
Gross profit Rs m14,80114,812 99.9%  
Depreciation Rs m1,8352,092 87.7%   
Interest Rs m160123 130.6%   
Profit before tax Rs m13,68113,890 98.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5332,401 105.5%   
Profit after tax Rs m11,14811,488 97.0%  
Gross profit margin %27.427.6 99.5%  
Effective tax rate %18.517.3 107.1%   
Net profit margin %20.721.4 96.6%  
BALANCE SHEET DATA
Current assets Rs m25,77934,370 75.0%   
Current liabilities Rs m12,80811,331 113.0%   
Net working cap to sales %24.142.9 56.1%  
Current ratio x2.03.0 66.4%  
Inventory Days Days2349 48.3%  
Debtors Days Days26 42.8%  
Net fixed assets Rs m41,31126,295 157.1%   
Share capital Rs m393254 154.9%   
"Free" reserves Rs m50,88346,763 108.8%   
Net worth Rs m51,27647,017 109.1%   
Long term debt Rs m1,999365 547.0%   
Total assets Rs m67,09060,664 110.6%  
Interest coverage x86.4114.2 75.7%   
Debt to equity ratio x00 501.6%  
Sales to assets ratio x0.80.9 90.8%   
Return on assets %16.919.1 88.1%  
Return on equity %21.724.4 89.0%  
Return on capital %26.029.6 87.8%  
Exports to sales %66.80-   
Imports to sales %12.70-   
Exports (fob) Rs m36,020NA-   
Imports (cif) Rs m6,845NA-   
Fx inflow Rs m36,02027,172 132.6%   
Fx outflow Rs m6,8457,949 86.1%   
Net fx Rs m29,17519,223 151.8%   
CASH FLOW
From Operations Rs m14,63410,901 134.2%  
From Investments Rs m-8,388-5,207 161.1%  
From Financial Activity Rs m-5,974-3,058 195.4%  
Net Cashflow Rs m2622,636 9.9%  

Share Holding

Indian Promoters % 69.1 46.3 149.3%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 17.8 44.0 40.4%  
FIIs % 6.0 11.0 54.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 53.7 56.6%  
Shareholders   106,437 115,335 92.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 24, 2022 03:31 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS